PMC7328543 1. Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature.
32636083
PMC7351017 2. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min.
32615038
PMC7330001 3. Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing.
32615934
PMC7332962 4. Antibody testing for coronavirus disease 2019: not ready for prime time.
32620675
PMC7327913 5. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.
32611558
PMC7347402 6. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
32647915
7. COVID-19 Serological Tests: How Well Do They Actually Perform?
32635444
8. Point-of-Care Diagnostic Services as an Integral Part of Health Services during the Novel Coronavirus 2019 Era.
32635234
9. COVID-19 Assessment with Bedside Lung Ultrasound in a Population of Intensive Care Patients Treated with Mechanical Ventilation and ECMO.
32630707
PMC7329266 10. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
32613308
PMC7334627 11. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis.
32623505
PMC7334123 12. Lung base CT findings in COVID-19 adult patients presenting with acute abdominal complaints: case series from a major New York City health system.
32623503
PMC7332743 13. Chest CT practice and protocols for COVID-19 from radiation dose management perspective.
32621238
PMC7332742 14. Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2.
32621237
PMC7331494 15. A deep learning approach to characterize 2019 coronavirus disease (COVID-19) pneumonia in chest CT images.
32617690
PMC7327490 16. Identification of common and severe COVID-19: the value of CT texture analysis and correlation with clinical characteristics.
32613287
PMC7341952 17. The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review.
32638613
PMC7320251 18. COVID-19: Current Trends in Invitro Diagnostics.
32641875
PMC7333224 19. Novel and economical apparatus to decrease direct droplet exposure during endoscopy in the ongoing COVID-19 pandemic: A hypothesis-generating innovation.
32621205
PMC7255184 20. Safety of Ultrasonic Enhancing Agents in Patients with COVID-19.
32624092
PMC7337781 21. An Initial Evaluation of the Agreement Between Two SARS-CoV-2 Serologic Assays.
32614446
PMC7332449 22. Testing COVID-19 tests faces methodological challenges.
32622902
23. Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19.
32636214
PMC7336953 24. Clinical evaluation of the BioFire(R) Respiratory Panel 2.1 and detection of SARS-CoV-2.
32650276
PMC7337688 25. ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank.
32623451
PMC7328559 26. Systematic review of artificial intelligence techniques in the detection and classification of COVID-19 medical images in terms of evaluation and benchmarking: Taxonomy analysis, challenges, future solutions and methodological aspects.
32646771
PMC7345451 27. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19.
32647900
PMC7338342 28. Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic.
32638333
PMC7341737 29. Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay.
32650037
30. An ultra-rapid real-time RT-PCR method using the PCR1100 to detect Severe Acute Respiratory Syndrome Coronavirus-2.
32611983
31. Chest CT evaluation of 11 persistent asymptomatic patients with SARS-CoV-2 infection.
32611980
PMC7327460 32. Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.
32613288
33. Magneto-Optical Nanostructures for Viral Sensing.
32610549
PMC7338506 34. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.
32632160
35. CT in relation to RT-PCR in diagnosing COVID-19 in The Netherlands: A prospective study.
32645053
36. CT characteristics and diagnostic value of COVID-19 in pregnancy.
32614854
PMC7350036 37. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era.
32633678
PMC7336103 38. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.
32631317
PMC7347874 39. Different computed tomography patterns of Coronavirus Disease 2019 (COVID-19) between survivors and non-survivors.
32647307
PMC7340769 40. Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening.
32643051
PMC7332917 41. The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.
32629085
42. Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?
32646015
43. [Preliminary Study on Clinical Features and CT Findings of Common-type Coronavirus Disease 2019 Patients in Peking Union Medical College Hospital].
32616135
44. [Comparison of Recovery Phase CT Features between Mild/moderate and Severe/critical Coronavirus Disease 2019 Patients].
32616134
{{tp|p=32636083|t=2020. Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature.|pdf=|usr=}}
{{tp|p=32615038|t=2020. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min.|pdf=|usr=}}
{{tp|p=32615934|t=2020. Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing.|pdf=|usr=}}
{{tp|p=32620675|t=2020. Antibody testing for coronavirus disease 2019: not ready for prime time.|pdf=|usr=}}
{{tp|p=32611558|t=2020. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=32647915|t=2020. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.|pdf=|usr=}}
{{tp|p=32635444|t=2020. COVID-19 Serological Tests: How Well Do They Actually Perform?|pdf=|usr=}}
{{tp|p=32635234|t=2020. Point-of-Care Diagnostic Services as an Integral Part of Health Services during the Novel Coronavirus 2019 Era.|pdf=|usr=}}
{{tp|p=32630707|t=2020. COVID-19 Assessment with Bedside Lung Ultrasound in a Population of Intensive Care Patients Treated with Mechanical Ventilation and ECMO.|pdf=|usr=}}
{{tp|p=32613308|t=2020. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.|pdf=|usr=}}
{{tp|p=32623505|t=2020. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis.|pdf=|usr=}}
{{tp|p=32623503|t=2020. Lung base CT findings in COVID-19 adult patients presenting with acute abdominal complaints: case series from a major New York City health system.|pdf=|usr=}}
{{tp|p=32621238|t=2020. Chest CT practice and protocols for COVID-19 from radiation dose management perspective.|pdf=|usr=}}
{{tp|p=32621237|t=2020. Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32617690|t=2020. A deep learning approach to characterize 2019 coronavirus disease (COVID-19) pneumonia in chest CT images.|pdf=|usr=}}
{{tp|p=32613287|t=2020. Identification of common and severe COVID-19: the value of CT texture analysis and correlation with clinical characteristics.|pdf=|usr=}}
{{tp|p=32638613|t=2020. The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review.|pdf=|usr=}}
{{tp|p=32641875|t=2020. COVID-19: Current Trends in Invitro Diagnostics.|pdf=|usr=}}
{{tp|p=32621205|t=2020. Novel and economical apparatus to decrease direct droplet exposure during endoscopy in the ongoing COVID-19 pandemic: A hypothesis-generating innovation.|pdf=|usr=}}
{{tp|p=32624092|t=2020. Safety of Ultrasonic Enhancing Agents in Patients with COVID-19.|pdf=|usr=}}
{{tp|p=32614446|t=2020. An Initial Evaluation of the Agreement Between Two SARS-CoV-2 Serologic Assays.|pdf=|usr=}}
{{tp|p=32622902|t=2020. Testing COVID-19 tests faces methodological challenges.|pdf=|usr=}}
{{tp|p=32636214|t=2020. Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19.|pdf=|usr=}}
{{tp|p=32650276|t=2020. Clinical evaluation of the BioFire(R) Respiratory Panel 2.1 and detection of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32623451|t=2020. ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank.|pdf=|usr=}}
{{tp|p=32646771|t=2020. Systematic review of artificial intelligence techniques in the detection and classification of COVID-19 medical images in terms of evaluation and benchmarking: Taxonomy analysis, challenges, future solutions and methodological aspects.|pdf=|usr=}}
{{tp|p=32647900|t=2020. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19.|pdf=|usr=}}
{{tp|p=32638333|t=2020. Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32650037|t=2020. Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay.|pdf=|usr=}}
{{tp|p=32611983|t=2020. An ultra-rapid real-time RT-PCR method using the PCR1100 to detect Severe Acute Respiratory Syndrome Coronavirus-2.|pdf=|usr=}}
{{tp|p=32611980|t=2020. Chest CT evaluation of 11 persistent asymptomatic patients with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32613288|t=2020. Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32610549|t=2020. Magneto-Optical Nanostructures for Viral Sensing.|pdf=|usr=}}
{{tp|p=32632160|t=2020. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.|pdf=|usr=}}
{{tp|p=32645053|t=2020. CT in relation to RT-PCR in diagnosing COVID-19 in The Netherlands: A prospective study.|pdf=|usr=}}
{{tp|p=32614854|t=2020. CT characteristics and diagnostic value of COVID-19 in pregnancy.|pdf=|usr=}}
{{tp|p=32633678|t=2020. Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era.|pdf=|usr=}}
{{tp|p=32631317|t=2020. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia.|pdf=|usr=}}
{{tp|p=32647307|t=2020. Different computed tomography patterns of Coronavirus Disease 2019 (COVID-19) between survivors and non-survivors.|pdf=|usr=}}
{{tp|p=32643051|t=2020. Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening.|pdf=|usr=}}
{{tp|p=32629085|t=2020. The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide.|pdf=|usr=}}
{{tp|p=32646015|t=2020. Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?|pdf=|usr=}}
{{tp|p=32616135|t=2020. [Preliminary Study on Clinical Features and CT Findings of Common-type Coronavirus Disease 2019 Patients in Peking Union Medical College Hospital].|pdf=|usr=}}
{{tp|p=32616134|t=2020. [Comparison of Recovery Phase CT Features between Mild/moderate and Severe/critical Coronavirus Disease 2019 Patients].|pdf=|usr=}}
45. Detecting the Coronavirus (COVID-19).
32627534
46. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
32618658
47. Feasibility, Reproducibility, and Clinical Validity of a Quantitative Chest X-Ray Assessment for COVID-19.
32618262
PMC7325509 48. Computed tomography scanning in the prone position for a critically hypoxic patient with COVID-19.
32626850
49. Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.
32638712
50. IS SURGICAL TRACHEOSTOMY BETTER THAN PERCUTANEOUS TRACHEOSTOMY IN COVID-19 POSITIVE PATIENTS?
32639386
51. Computed tomography of covid-19 pneumonia.
32646872
52. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2.
32628628
53. Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.
32619192
54. A Systematic Review of CT Chest in COVID-19 Diagnosis and its Potential Application in a Surgical Setting.
32644268
55. Admission fasting blood glucose predicts 30-day poor outcome in patients hospitalized for COVID-19 pneumonia.
32627338
56. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
32641174
57. Dynamic evolution of lung abnormalities evaluated by quantitative CT techniques in patients with COVID-19 infection.
32624074
58. The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups.
32635755
59. Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.
32635752
60. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.
32628976
61. A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.
32623831
62. Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms.
32611796
63. Preanalytical issues affecting the diagnosis of COVID-19.
32631944
64. Initial Results of the Use of a Standardized Diagnostic Criteria for Chest Computed Tomography Findings in Coronavirus Disease 2019.
32649426
65. Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection.
32613877
66. Serum KL-6 can distinguish between different phenotypes of severe COVID-19.
32633842
67. Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2.
32621616
68. Re: "Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method"-Could Telementoring of Lung Ultrasound Reduce Health Care Provider Risks, Especially for Paucisymptomatic Home-Isolating Patients?
32639037
69. Lung Ultrasound During the COVID-19 Pandemic: Building a Mobile Lung Ultrasound Unit.
32621619
70. Laboratory Assay Evaluation Demystified: A Review of Key Factors Influencing Interpretation of Test Results Using Different Assays for SARS-CoV-2 Infection Diagnosis.
32634229
71. Chest computed tomography in recovered and discharged COVID-19 patients.
32643649
72. COVID-19 spurs wave of innovative diagnostics.
32641849
73. First NGS-based COVID-19 diagnostic.
32641848
74. Single photon emission computed tomography-computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?
32649574
75. How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab?
32611532
76. COVID-19 Clinical Diagnostics and Testing Technology.
32643218
77. Reverse Batwing sign in COVID-19 Pneumonia.
32649770
78. Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population.
32627200
{{tp|p=32627534|t=2020. Detecting the Coronavirus (COVID-19).|pdf=|usr=}}
{{tp|p=32618658|t=2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.|pdf=|usr=}}
{{tp|p=32618262|t=2020. Feasibility, Reproducibility, and Clinical Validity of a Quantitative Chest X-Ray Assessment for COVID-19.|pdf=|usr=}}
{{tp|p=32626850|t=2020. Computed tomography scanning in the prone position for a critically hypoxic patient with COVID-19.|pdf=|usr=}}
{{tp|p=32638712|t=2020. Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome.|pdf=|usr=}}
{{tp|p=32639386|t=2020. IS SURGICAL TRACHEOSTOMY BETTER THAN PERCUTANEOUS TRACHEOSTOMY IN COVID-19 POSITIVE PATIENTS?|pdf=|usr=}}
{{tp|p=32646872|t=2020. Computed tomography of covid-19 pneumonia.|pdf=|usr=}}
{{tp|p=32628628|t=2020. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32619192|t=2020. Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice.|pdf=|usr=}}
{{tp|p=32644268|t=2020. A Systematic Review of CT Chest in COVID-19 Diagnosis and its Potential Application in a Surgical Setting.|pdf=|usr=}}
{{tp|p=32627338|t=2020. Admission fasting blood glucose predicts 30-day poor outcome in patients hospitalized for COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=32641174|t=2020. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.|pdf=|usr=}}
{{tp|p=32624074|t=2020. Dynamic evolution of lung abnormalities evaluated by quantitative CT techniques in patients with COVID-19 infection.|pdf=|usr=}}
{{tp|p=32635755|t=2020. The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups.|pdf=|usr=}}
{{tp|p=32635752|t=2020. Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.|pdf=|usr=}}
{{tp|p=32628976|t=2020. SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype.|pdf=|usr=}}
{{tp|p=32623831|t=2020. A role for human leucocyte antigens in the susceptibility to SARS-Cov-2 infection observed in transplant patients.|pdf=|usr=}}
{{tp|p=32611796|t=2020. Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial Platforms.|pdf=|usr=}}
{{tp|p=32631944|t=2020. Preanalytical issues affecting the diagnosis of COVID-19.|pdf=|usr=}}
{{tp|p=32649426|t=2020. Initial Results of the Use of a Standardized Diagnostic Criteria for Chest Computed Tomography Findings in Coronavirus Disease 2019.|pdf=|usr=}}
{{tp|p=32613877|t=2020. Oropharyngeal Secretion as Alternative for SARS-CoV-2 Detection.|pdf=|usr=}}
{{tp|p=32633842|t=2020. Serum KL-6 can distinguish between different phenotypes of severe COVID-19.|pdf=|usr=}}
{{tp|p=32621616|t=2020. Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32639037|t=2020. Re: "Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method"-Could Telementoring of Lung Ultrasound Reduce Health Care Provider Risks, Especially for Paucisymptomatic Home-Isolating Patients?|pdf=|usr=}}
{{tp|p=32621619|t=2020. Lung Ultrasound During the COVID-19 Pandemic: Building a Mobile Lung Ultrasound Unit.|pdf=|usr=}}
{{tp|p=32634229|t=2020. Laboratory Assay Evaluation Demystified: A Review of Key Factors Influencing Interpretation of Test Results Using Different Assays for SARS-CoV-2 Infection Diagnosis.|pdf=|usr=}}
{{tp|p=32643649|t=2020. Chest computed tomography in recovered and discharged COVID-19 patients.|pdf=|usr=}}
{{tp|p=32641849|t=2020. COVID-19 spurs wave of innovative diagnostics.|pdf=|usr=}}
{{tp|p=32641848|t=2020. First NGS-based COVID-19 diagnostic.|pdf=|usr=}}
{{tp|p=32649574|t=2020. Single photon emission computed tomography-computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?|pdf=|usr=}}
{{tp|p=32611532|t=2020. How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab?|pdf=|usr=}}
{{tp|p=32643218|t=2020. COVID-19 Clinical Diagnostics and Testing Technology.|pdf=|usr=}}
{{tp|p=32649770|t=2020. Reverse Batwing sign in COVID-19 Pneumonia.|pdf=|usr=}}
{{tp|p=32627200|t=2020. Novel multiple swab method enables high efficiency in SARS-CoV-2 screenings without loss of sensitivity for screening of a complete population.|pdf=|usr=}}